author-photo

Niall C. Tebbutt

Ludwig Institute for Cancer Research
Austin Hospital
University of Melbourne

345

Papers

15309

Citations

Citation Trend

Filter By

Papers (219) Sort By

Journal Conference Others

Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis

2021 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Dual anti-angiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Update on optimal management for pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.

2021 Expert Review of Anticancer Therapy
Show All
- Source
- Cite
- Save
Citations (0)
FORECAST-1: Feasibility of organoid response assessment to define effective treatments for patients with colorectal cancer after failure of standard therapy.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.

2021 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (1)
Evaluation of 18F-FMISO PET and 18F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Rapid resistance of FGFR-driven gastric cancers to regorafenib and targeted FGFR inhibitors can be overcome by parallel inhibition of MEK

2021 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (1)
O-7 FOLFIRI ± napabucasin in patients with previously treated metastatic colorectal cancer: Overall survival results from the phase 3 CanStem303C study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
435P The AGITG Modulate study: Randomised phase II study testing manipulation of the tumour micro environment (TME) to enable synergy with PD1 inhibitors in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)